다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Medicine : the continuously updated review of clinical medicine, v.40 no.1, 2012년, pp.1 - 4
Caley, Andrew (Andrew Caley MRCP is a Specialist Registrar on the South East Wales Clinical Oncology Training Programme, Cardiff, UK. Conflicts of interest: none declared) , Kanji, Alpa (Andrew Caley MRCP is a Specialist Registrar on the South East Wales Clinical Oncology Training Programme, Cardiff, UK. Conflicts of interest: none declared) , Tanguay, Jake (Andrew Caley MRCP is a Specialist Registrar on the South East Wales Clinical Oncology Training Programme, Cardiff, UK. Conflicts of interest: none declared)
AI-Helper
AbstractAdjuvant therapy is used to reduce the risk of cancer recurrence and improve survival. It is usually given after patients have had radical (i.e. potentially curative) treatment targeting the primary tumour, but there are some circumstances where treatment is given beforehand (termed ‘n...
Freter 2008 The chemotherapy source book The principles of chemotherapy
Lancet Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) 365 1687 2005 10.1016/S0140-6736(05)66544-0 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Lancet Oncol Dowsett 9 45 2008 10.1016/S1470-2045(07)70385-6 Meta-analysis of breast cancer outcomes in adjuvant trials Tamoxifen, Alone or in Combination (ATAC) Trialists’ Group. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
N Engl J Med BIG 1-98 Collaborative Group 361 766 2009 10.1056/NEJMoa0810818 Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer
Lancet van de Velde 377 321 2011 10.1016/S0140-6736(10)62312-4 Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
N Engl J Med Goss 349 1793 2003 10.1056/NEJMoa032312 A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
Cochrane Database Syst Rev Ferguson 4 2007 10.1002/14651858.CD004421.pub2 Taxanes for adjuvant treatment of early breast cancer
Future Oncol Zujewski 4 603 2008 10.2217/14796694.4.5.603 Trial assessing individualized options for treatment for breast cancer: the TAILORx trial
N Engl J Med Romond 353 1673 2005 10.1056/NEJMoa052122 Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
Lancet Smith 369 29 2007 10.1016/S0140-6736(07)60028-2 HERA study team. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
Lancet EBCTCG 366 2087 2005 10.1016/S0140-6736(05)67887-7 Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials
Lancet Cunnigham 370 1980 2007 10.1016/S0140-6736(07)61841-8 Adjuvant chemotherapy of colorectal cancer
Clin Oncol Jonker 23 314 2011 10.1016/j.clon.2011.02.010 Adjuvant systemic chemotherapy for stage II and III colon cancer after complete resection: an updated practice guideline
N Engl J Med Sauer 351 1731 2004 10.1056/NEJMoa040694 German rectal cancer study group. Preoperative versus postoperative chemoradiotherapy for rectal cancer
Adjuvant Online. www.adjuvantonline.com (accessed 31 May 2011).
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.